Dietary supplementation exerts neuroprotective effects in ischemic stroke model

Takao Yasuhara, Koichi Hara, Mina Maki, Tadashi Masuda, Cyndy D. Sanberg, Paul R. Sanberg, Paula C. Bickford, Cesar V. Borlongan

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This study examined whether dietary supplementation can be used to protect against ischemic stroke. Two groups of adult male Sprague-Dawley rats initially received NT-020, a proprietary formulation of blueberry, green tea, Vitamin D3, and carnosine (n = 8), or vehicle (n = 7). Dosing for NT-020 and vehicle consisted of daily oral administration (using a gavage) over a 2-week period. On day 14 following the last drug treatment, all animals underwent the stroke surgery using the transient 1-hour suture occlusion of middle cerebral artery (MCAo). To reveal the functional effects of NT-020, animals were subjected to established behavioral tests just prior to stroke surgery and again on day 14 post-stroke. ANOVA revealed significant treatment effects (p <0.05), characterized by reductions of 11.8% and 24.4% in motor asymmetry and neurologic dysfunction, respectively, in NT-020-treated stroke animals compared to vehicle-treated stroke animals. Evaluation of cerebral infarction revealed a significant 75% decrement in mean glial scar area in the ischemic striatum of NT-020-treated stroke animals compared to that of vehicle-treated stroke animals (p <0.0005). Quantitative analysis of subventricular zone's cell proliferative activity revealed at least a one-fold increment in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0005). Similarly, quantitative analysis of BrdU labeling in the ischemic striatal penumbra revealed at least a three-fold increase in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0001). In addition, widespread double labeling of cells with BrdU and doublecortin was detected in NT-020-treated stroke brains (intact side 17% and ischemic side 75%), which was significantly higher than those seen in vehicle-treated stroke brains (intact side 5% and ischemic side 13%) (p <0.05). In contrast, only a small number of cells in NT-020-treated stroke brains double labeled with BrdU and GFAP (intact side 1% and ischemic side 2%), which was significantly lower than those vehicle-treated stroke brains (intact side 18% and ischemic side 35%) (p <0.0001). Endogenous neurogenic factors were also significantly upregulated in the ischemic brains of NT-020-treated stroke animals. These data demonstrate the remarkable neuroprotective effects of NT-020 when given prior to stroke, possibly acting via its neurogenic potential.

Original languageEnglish
Pages (from-to)201-214
Number of pages14
JournalRejuvenation Research
Volume11
Issue number1
DOIs
Publication statusPublished - Feb 1 2008
Externally publishedYes

Fingerprint

Neuroprotective Agents
Dietary Supplements
Stroke
Bromodeoxyuridine
Brain
Blueberry Plants
Carnosine
Corpus Striatum
Cholecalciferol
Lateral Ventricles
Middle Cerebral Artery Infarction
Cerebral Infarction
Tea
Neurologic Manifestations

ASJC Scopus subject areas

  • Ageing

Cite this

Yasuhara, T., Hara, K., Maki, M., Masuda, T., Sanberg, C. D., Sanberg, P. R., ... Borlongan, C. V. (2008). Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Research, 11(1), 201-214. https://doi.org/10.1089/rej.2007.0608

Dietary supplementation exerts neuroprotective effects in ischemic stroke model. / Yasuhara, Takao; Hara, Koichi; Maki, Mina; Masuda, Tadashi; Sanberg, Cyndy D.; Sanberg, Paul R.; Bickford, Paula C.; Borlongan, Cesar V.

In: Rejuvenation Research, Vol. 11, No. 1, 01.02.2008, p. 201-214.

Research output: Contribution to journalArticle

Yasuhara, T, Hara, K, Maki, M, Masuda, T, Sanberg, CD, Sanberg, PR, Bickford, PC & Borlongan, CV 2008, 'Dietary supplementation exerts neuroprotective effects in ischemic stroke model', Rejuvenation Research, vol. 11, no. 1, pp. 201-214. https://doi.org/10.1089/rej.2007.0608
Yasuhara, Takao ; Hara, Koichi ; Maki, Mina ; Masuda, Tadashi ; Sanberg, Cyndy D. ; Sanberg, Paul R. ; Bickford, Paula C. ; Borlongan, Cesar V. / Dietary supplementation exerts neuroprotective effects in ischemic stroke model. In: Rejuvenation Research. 2008 ; Vol. 11, No. 1. pp. 201-214.
@article{4fed1b5ec26148688f44597be81424f0,
title = "Dietary supplementation exerts neuroprotective effects in ischemic stroke model",
abstract = "This study examined whether dietary supplementation can be used to protect against ischemic stroke. Two groups of adult male Sprague-Dawley rats initially received NT-020, a proprietary formulation of blueberry, green tea, Vitamin D3, and carnosine (n = 8), or vehicle (n = 7). Dosing for NT-020 and vehicle consisted of daily oral administration (using a gavage) over a 2-week period. On day 14 following the last drug treatment, all animals underwent the stroke surgery using the transient 1-hour suture occlusion of middle cerebral artery (MCAo). To reveal the functional effects of NT-020, animals were subjected to established behavioral tests just prior to stroke surgery and again on day 14 post-stroke. ANOVA revealed significant treatment effects (p <0.05), characterized by reductions of 11.8{\%} and 24.4{\%} in motor asymmetry and neurologic dysfunction, respectively, in NT-020-treated stroke animals compared to vehicle-treated stroke animals. Evaluation of cerebral infarction revealed a significant 75{\%} decrement in mean glial scar area in the ischemic striatum of NT-020-treated stroke animals compared to that of vehicle-treated stroke animals (p <0.0005). Quantitative analysis of subventricular zone's cell proliferative activity revealed at least a one-fold increment in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0005). Similarly, quantitative analysis of BrdU labeling in the ischemic striatal penumbra revealed at least a three-fold increase in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0001). In addition, widespread double labeling of cells with BrdU and doublecortin was detected in NT-020-treated stroke brains (intact side 17{\%} and ischemic side 75{\%}), which was significantly higher than those seen in vehicle-treated stroke brains (intact side 5{\%} and ischemic side 13{\%}) (p <0.05). In contrast, only a small number of cells in NT-020-treated stroke brains double labeled with BrdU and GFAP (intact side 1{\%} and ischemic side 2{\%}), which was significantly lower than those vehicle-treated stroke brains (intact side 18{\%} and ischemic side 35{\%}) (p <0.0001). Endogenous neurogenic factors were also significantly upregulated in the ischemic brains of NT-020-treated stroke animals. These data demonstrate the remarkable neuroprotective effects of NT-020 when given prior to stroke, possibly acting via its neurogenic potential.",
author = "Takao Yasuhara and Koichi Hara and Mina Maki and Tadashi Masuda and Sanberg, {Cyndy D.} and Sanberg, {Paul R.} and Bickford, {Paula C.} and Borlongan, {Cesar V.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1089/rej.2007.0608",
language = "English",
volume = "11",
pages = "201--214",
journal = "Rejuvenation Research",
issn = "1549-1684",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Dietary supplementation exerts neuroprotective effects in ischemic stroke model

AU - Yasuhara, Takao

AU - Hara, Koichi

AU - Maki, Mina

AU - Masuda, Tadashi

AU - Sanberg, Cyndy D.

AU - Sanberg, Paul R.

AU - Bickford, Paula C.

AU - Borlongan, Cesar V.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - This study examined whether dietary supplementation can be used to protect against ischemic stroke. Two groups of adult male Sprague-Dawley rats initially received NT-020, a proprietary formulation of blueberry, green tea, Vitamin D3, and carnosine (n = 8), or vehicle (n = 7). Dosing for NT-020 and vehicle consisted of daily oral administration (using a gavage) over a 2-week period. On day 14 following the last drug treatment, all animals underwent the stroke surgery using the transient 1-hour suture occlusion of middle cerebral artery (MCAo). To reveal the functional effects of NT-020, animals were subjected to established behavioral tests just prior to stroke surgery and again on day 14 post-stroke. ANOVA revealed significant treatment effects (p <0.05), characterized by reductions of 11.8% and 24.4% in motor asymmetry and neurologic dysfunction, respectively, in NT-020-treated stroke animals compared to vehicle-treated stroke animals. Evaluation of cerebral infarction revealed a significant 75% decrement in mean glial scar area in the ischemic striatum of NT-020-treated stroke animals compared to that of vehicle-treated stroke animals (p <0.0005). Quantitative analysis of subventricular zone's cell proliferative activity revealed at least a one-fold increment in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0005). Similarly, quantitative analysis of BrdU labeling in the ischemic striatal penumbra revealed at least a three-fold increase in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0001). In addition, widespread double labeling of cells with BrdU and doublecortin was detected in NT-020-treated stroke brains (intact side 17% and ischemic side 75%), which was significantly higher than those seen in vehicle-treated stroke brains (intact side 5% and ischemic side 13%) (p <0.05). In contrast, only a small number of cells in NT-020-treated stroke brains double labeled with BrdU and GFAP (intact side 1% and ischemic side 2%), which was significantly lower than those vehicle-treated stroke brains (intact side 18% and ischemic side 35%) (p <0.0001). Endogenous neurogenic factors were also significantly upregulated in the ischemic brains of NT-020-treated stroke animals. These data demonstrate the remarkable neuroprotective effects of NT-020 when given prior to stroke, possibly acting via its neurogenic potential.

AB - This study examined whether dietary supplementation can be used to protect against ischemic stroke. Two groups of adult male Sprague-Dawley rats initially received NT-020, a proprietary formulation of blueberry, green tea, Vitamin D3, and carnosine (n = 8), or vehicle (n = 7). Dosing for NT-020 and vehicle consisted of daily oral administration (using a gavage) over a 2-week period. On day 14 following the last drug treatment, all animals underwent the stroke surgery using the transient 1-hour suture occlusion of middle cerebral artery (MCAo). To reveal the functional effects of NT-020, animals were subjected to established behavioral tests just prior to stroke surgery and again on day 14 post-stroke. ANOVA revealed significant treatment effects (p <0.05), characterized by reductions of 11.8% and 24.4% in motor asymmetry and neurologic dysfunction, respectively, in NT-020-treated stroke animals compared to vehicle-treated stroke animals. Evaluation of cerebral infarction revealed a significant 75% decrement in mean glial scar area in the ischemic striatum of NT-020-treated stroke animals compared to that of vehicle-treated stroke animals (p <0.0005). Quantitative analysis of subventricular zone's cell proliferative activity revealed at least a one-fold increment in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0005). Similarly, quantitative analysis of BrdU labeling in the ischemic striatal penumbra revealed at least a three-fold increase in the number of BrdU-positive cells in the NT-020-treated stroke brains compared to vehicle-treated stroke brains (p <0.0001). In addition, widespread double labeling of cells with BrdU and doublecortin was detected in NT-020-treated stroke brains (intact side 17% and ischemic side 75%), which was significantly higher than those seen in vehicle-treated stroke brains (intact side 5% and ischemic side 13%) (p <0.05). In contrast, only a small number of cells in NT-020-treated stroke brains double labeled with BrdU and GFAP (intact side 1% and ischemic side 2%), which was significantly lower than those vehicle-treated stroke brains (intact side 18% and ischemic side 35%) (p <0.0001). Endogenous neurogenic factors were also significantly upregulated in the ischemic brains of NT-020-treated stroke animals. These data demonstrate the remarkable neuroprotective effects of NT-020 when given prior to stroke, possibly acting via its neurogenic potential.

UR - http://www.scopus.com/inward/record.url?scp=39449128517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449128517&partnerID=8YFLogxK

U2 - 10.1089/rej.2007.0608

DO - 10.1089/rej.2007.0608

M3 - Article

C2 - 18260778

AN - SCOPUS:39449128517

VL - 11

SP - 201

EP - 214

JO - Rejuvenation Research

JF - Rejuvenation Research

SN - 1549-1684

IS - 1

ER -